KKR (KKR) completed a $250 million investment in Henry Schein (HSIC) and holds a 12% stake in the health-care solution provider.
KKR's executive adviser, William Daniel, has joined Henry Schein's board in connection with the investment.
He joins Max Lin, a partner at KKR and leader of the firm's health care industry team in the Americas, who became a member of the board in early May, Henry Schein said Friday in a statement.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。